The impact of dipeptidyl peptidase 4 inhibition on incretin effect, glucose tolerance, and gastrointestinal-mediated glucose disposal in healthy subjects.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- The impact of dipeptidyl peptidase 4 inhibition on incretin effect, glucose tolerance, and gastrointestinal-mediated glucose disposal in healthy subjects.
- Published In:
- European journal of endocrinology, 171(3), 353-62 (2014)
- Authors:
- Rhee, N A, Østoft, S H, Holst, J J(2), Deacon, C F, Vilsbøll, T, Knop, F K
- Database ID:
- RPEP-02484
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-02484APA
Rhee, N A; Østoft, S H; Holst, J J; Deacon, C F; Vilsbøll, T; Knop, F K. (2014). The impact of dipeptidyl peptidase 4 inhibition on incretin effect, glucose tolerance, and gastrointestinal-mediated glucose disposal in healthy subjects.. European journal of endocrinology, 171(3), 353-62. https://doi.org/10.1530/EJE-14-0314
MLA
Rhee, N A, et al. "The impact of dipeptidyl peptidase 4 inhibition on incretin effect, glucose tolerance, and gastrointestinal-mediated glucose disposal in healthy subjects.." European journal of endocrinology, 2014. https://doi.org/10.1530/EJE-14-0314
RethinkPeptides
RethinkPeptides Research Database. "The impact of dipeptidyl peptidase 4 inhibition on incretin ..." RPEP-02484. Retrieved from https://rethinkpeptides.com/research/rhee-2014-the-impact-of-dipeptidyl
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.